in this issue
World News and Views :: Top of the News
Clinigen and PCAS Sign API Supply Deal
4:03 AM MST | January 6, 2012 | Deepti Ramesh
Clinigen Healthcare, a division of Clinigen Group (Burton-on-Trent, U.K.), has signed a long-term global supply agreement with PCAS (Longjumeau, France), a leading active pharmaceutical ingredient (API) manufacturer, for the production of the Foscavir drug substance. PCAS will manufacture foscarnet sodium hexahydrate, the API contained in Clinigen’s Foscavir, while Clinigen will leverage its own infrastructure and global network of partners to supply the medicine worldwide, under the agreement. Clinigen holds marketing authorizations to sell Foscavir as a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee